Indrayani Biotech Limited (BOM:526445)

Indrayani Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	2.88	5.82	30.37	15.03	6.79
Short-Term Investments	-	262.11	296.7	96.58	6.77	-
Cash & Short-Term Investments	265	265	302.52	126.94	21.8	6.79
Cash Growth	-12.40%	-12.40%	138.31%	482.33%	221.19%	-51.59%
Accounts Receivable	-	586.9	395.29	299.72	140.99	47.68
Other Receivables	-	405.58	245.41	177.15	12.83	14.57
Receivables	-	1,078	709.17	500.53	153.82	62.25
Inventory	-	413.42	423.51	122.14	15.32	10.9
Other Current Assets	-	22.84	14.56	25.62	4.97	11.58
Total Current Assets	-	1,779	1,450	775.23	195.91	91.52
Property, Plant & Equipment	-	600.04	593.77	478.56	259.38	252.52
Long-Term Investments	-	2.48	2.23	2.23	0.01	0.12
Goodwill	-	233.47	233.47	233.47	38.41	38.41
Other Intangible Assets	-	0.01	-	0.15	-	-
Long-Term Deferred Tax Assets	-	-0.49	3.32	0.38	-	-
Other Long-Term Assets	-	64.04	57.46	69.6	20.3	17.98
Total Assets	-	2,679	2,340	1,560	514.01	400.55
Accounts Payable	-	235.83	373.9	227.38	58.2	33.36
Accrued Expenses	-	61.43	55.3	54.82	22.03	10.89
Short-Term Debt	-	704.36	398.51	314.31	111.03	73.83
Current Portion of Long-Term Debt	-	12.22	12.16	19.44	-	-
Current Portion of Leases	-	-	7.93	11.25	3.57	-
Current Income Taxes Payable	-	8.21	6.19	2.01	-	-
Current Unearned Revenue	-	0.35	0.33	0.12	-	-
Other Current Liabilities	-	2.44	16.4	89.77	-	-
Total Current Liabilities	-	1,025	870.72	719.1	194.82	118.07
Long-Term Debt	-	654.15	665.97	293.7	67.85	81.54
Long-Term Leases	-	-	40.67	63.16	5.5	-
Long-Term Deferred Tax Liabilities	-	-	-	0.14	0.14	0.14
Other Long-Term Liabilities	-	0.75	-	-	-	-
Total Liabilities	-	1,680	1,577	1,076	268.31	199.75
Common Stock	-	455.36	455.36	342.27	342.27	342.27
Additional Paid-In Capital	-	201.74	126.64	114.01	0.09	-
Retained Earnings	-	33.11	48.94	-13.36	-100.72	-145.12
Comprehensive Income & Other	-	34.88	41.18	15.44	-	0.05
Total Common Equity	725.1	725.1	672.12	458.37	241.63	197.2
Minority Interest	-	274.07	90.54	-67.34	4.06	3.6
Shareholders' Equity	999.16	999.16	762.66	483.53	245.7	200.8
Total Liabilities & Equity	-	2,679	2,340	1,560	514.01	400.55
Total Debt	1,371	1,371	1,125	701.86	187.94	155.36
Net Cash (Debt)	-1,106	-1,106	-822.72	-574.92	-166.15	-148.58
Net Cash Per Share	-21.20	-24.28	-18.07	-13.22	-4.85	-4.17
Filing Date Shares Outstanding	52.17	45.54	45.54	34.23	34.23	34.23
Total Common Shares Outstanding	52.17	45.54	45.54	34.23	34.23	34.23
Working Capital	-	754.51	579.04	56.13	1.08	-26.55
Book Value Per Share	11.48	15.92	14.76	13.39	7.06	5.76
Tangible Book Value	491.61	491.61	438.65	224.75	203.22	158.79
Tangible Book Value Per Share	7.78	10.80	9.63	6.57	5.94	4.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.